Pediatric Hodgkin Lymphoma Treatment Trial With Low Cumulative Doses of Chemotherapy Agents and Reduced Radiation.

This trial proposes a therapy for pediatric Hodgkin lymphoma with the objective of achieving high levels of long lasting complete remission with less risk of late effects. Patients of both genders, between 2 and 18 years, with newly diagnosed classical Hodgkin lymphoma are admitted. Initial staging provides stratification in three groups: low, intermediate and high risk. An initial set of two chemotherapy courses is administered to all cases after which a new disease assessment is performed. According to disease response a final therapy group is assigned. Rapid early responders benefit from

Trial Details

NCT ID
NCT03500133
Phase
PHASE4
Sponsor
Hospital JP Garrahan
Status
RECRUITING
Cancer Type
Non-Hodgkin Lymphoma Lymphoma
Interventions
  • No radiotherapy if CR at the end of chemotherapy.
  • Low risk with complete early response after two cycles of ABVD chemotherapy schedule. Only one more ABVD course is delivered.
  • Low risk with partial remisssion after 4 cycles of ABVD chemotherapy schedule. Two ESHAP courses are delivered.
  • IN 30Gy RT in case of PR at the end of chemotherapy
  • Intermediate risk with complete early response after two cycles of ABVD chemotherapy schedule. Three more ABVD courses are delivered.
  • Intermediate risk with partial remission after two cycles of ABVD chemotherapy schedule. Four more chemotherapy courses are delivered alternating ESHAP and ABVD.
Locations (sample)
  • Buenos Aires, Buenos Aires F.D., Argentina|-34.61315,-58.37723

Key Eligibility Criteria

  • Histopathological diagnosis of classical Hodgkin lymphoma.
  • Normal renal, hepatic, pulmonary and metabolic function standards.
  • Informed consent signed by patient and/or legal caretakers.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Non-Hodgkin Lymphoma Lymphoma Trials on Trialify →